BRIEF-Sanofi genzyme extends its multiple myeloma journey partners program

* Sanofi genzyme extends its multiple myeloma journey partners program to cities nationwide to help improve patient outcomes through peer-to-peer education Source text for Eikon: Further company coverage:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.